Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Leukocyte L1 Antigen Complex | 2 | 2017 | 238 | 1.14 | Why? |
| Silicates | 1 | 2018 | 19 | 0.74 | Why? |
| Helicobacter pylori | 2 | 2018 | 262 | 0.71 | Why? |
| Gentamicins | 1 | 2018 | 76 | 0.71 | Why? |
| Coated Materials, Biocompatible | 1 | 2018 | 113 | 0.69 | Why? |
| Titanium | 1 | 2018 | 175 | 0.65 | Why? |
| Helicobacter Infections | 2 | 2018 | 216 | 0.62 | Why? |
| Republic of Korea | 16 | 2021 | 5858 | 0.49 | Why? |
| Staphylococcal Infections | 2 | 2018 | 1099 | 0.47 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.46 | Why? |
| Pediatric Obesity | 1 | 2017 | 492 | 0.44 | Why? |
| Feces | 3 | 2018 | 4235 | 0.38 | Why? |
| Asymptomatic Diseases | 2 | 2020 | 3444 | 0.37 | Why? |
| Shock, Septic | 4 | 2018 | 1313 | 0.35 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 907 | 0.34 | Why? |
| Cesarean Section | 1 | 2017 | 2089 | 0.32 | Why? |
| Breast Feeding | 1 | 2017 | 1585 | 0.31 | Why? |
| Anti-Bacterial Agents | 6 | 2019 | 10083 | 0.29 | Why? |
| Disinfection | 1 | 2018 | 2912 | 0.29 | Why? |
| Bacteremia | 4 | 2019 | 1372 | 0.28 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.26 | Why? |
| Inflammatory Bowel Diseases | 2 | 2019 | 3209 | 0.25 | Why? |
| Stomach Neoplasms | 2 | 2019 | 477 | 0.24 | Why? |
| Stomach Diseases | 1 | 2020 | 27 | 0.21 | Why? |
| Cross Infection | 3 | 2020 | 8675 | 0.21 | Why? |
| Gastrectomy | 2 | 2019 | 225 | 0.21 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.21 | Why? |
| Photochemistry | 1 | 2018 | 13 | 0.20 | Why? |
| Peptide Nucleic Acids | 1 | 2018 | 28 | 0.19 | Why? |
| Stenotrophomonas maltophilia | 1 | 2019 | 63 | 0.19 | Why? |
| Tuberculosis, Urogenital | 1 | 2018 | 12 | 0.19 | Why? |
| Photochemical Processes | 1 | 2018 | 75 | 0.19 | Why? |
| Nafcillin | 1 | 2018 | 4 | 0.19 | Why? |
| Pentastomida | 1 | 2017 | 1 | 0.18 | Why? |
| Maxillary Diseases | 1 | 2017 | 11 | 0.18 | Why? |
| Catalysis | 1 | 2018 | 253 | 0.18 | Why? |
| Bisphosphonate-Associated Osteonecrosis of the Jaw | 1 | 2017 | 18 | 0.18 | Why? |
| Clarithromycin | 1 | 2018 | 112 | 0.18 | Why? |
| Paternity | 1 | 2017 | 7 | 0.17 | Why? |
| Quinolones | 1 | 2019 | 167 | 0.17 | Why? |
| Fungemia | 1 | 2018 | 86 | 0.17 | Why? |
| Chlorides | 1 | 2017 | 82 | 0.17 | Why? |
| Liver Abscess, Pyogenic | 1 | 2017 | 14 | 0.17 | Why? |
| DNA Fingerprinting | 1 | 2017 | 41 | 0.17 | Why? |
| Histiocytic Necrotizing Lymphadenitis | 1 | 2017 | 23 | 0.17 | Why? |
| Maxilla | 1 | 2017 | 70 | 0.17 | Why? |
| Surface Properties | 1 | 2018 | 448 | 0.17 | Why? |
| Gastric Mucosa | 1 | 2018 | 141 | 0.17 | Why? |
| Environment Design | 1 | 2018 | 183 | 0.16 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.16 | Why? |
| Osteogenesis | 1 | 2017 | 95 | 0.16 | Why? |
| Erythrocyte Indices | 1 | 2018 | 207 | 0.16 | Why? |
| Parasitic Diseases | 1 | 2017 | 84 | 0.16 | Why? |
| Chlorhexidine | 1 | 2018 | 176 | 0.16 | Why? |
| Microsatellite Repeats | 1 | 2017 | 99 | 0.16 | Why? |
| Patient Care Bundles | 1 | 2018 | 137 | 0.15 | Why? |
| Klebsiella pneumoniae | 2 | 2019 | 658 | 0.15 | Why? |
| Anthropometry | 1 | 2017 | 233 | 0.15 | Why? |
| Intraoperative Care | 1 | 2017 | 238 | 0.15 | Why? |
| Glycopeptides | 1 | 2018 | 199 | 0.15 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.15 | Why? |
| Immunophenotyping | 1 | 2020 | 1290 | 0.15 | Why? |
| Proton Pump Inhibitors | 1 | 2020 | 377 | 0.15 | Why? |
| Kidney Function Tests | 1 | 2017 | 520 | 0.14 | Why? |
| Drug Resistance, Bacterial | 3 | 2019 | 1414 | 0.14 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.14 | Why? |
| Fungi | 1 | 2018 | 471 | 0.14 | Why? |
| Candidemia | 1 | 2019 | 353 | 0.14 | Why? |
| Gastrointestinal Agents | 1 | 2019 | 393 | 0.14 | Why? |
| Lactic Acid | 1 | 2017 | 393 | 0.14 | Why? |
| Klebsiella Infections | 1 | 2019 | 466 | 0.13 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2019 | 398 | 0.13 | Why? |
| Male | 29 | 2021 | 367725 | 0.13 | Why? |
| Catheter-Related Infections | 1 | 2018 | 381 | 0.13 | Why? |
| Mental Health | 1 | 2020 | 15770 | 0.13 | Why? |
| Reference Values | 1 | 2017 | 795 | 0.13 | Why? |
| Surgical Wound Infection | 1 | 2019 | 501 | 0.13 | Why? |
| Health Care Costs | 2 | 2019 | 1007 | 0.13 | Why? |
| Tenofovir | 1 | 2017 | 449 | 0.13 | Why? |
| Pseudomonas Infections | 1 | 2018 | 425 | 0.13 | Why? |
| Liver Function Tests | 2 | 2017 | 1325 | 0.13 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.12 | Why? |
| Bacterial Proteins | 2 | 2019 | 1318 | 0.12 | Why? |
| Female | 27 | 2021 | 380317 | 0.12 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2020 | 2483 | 0.12 | Why? |
| Thyroid Neoplasms | 1 | 2017 | 422 | 0.12 | Why? |
| Retrospective Studies | 16 | 2021 | 105322 | 0.12 | Why? |
| Tertiary Care Centers | 5 | 2020 | 8248 | 0.11 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.11 | Why? |
| Pneumonia, Bacterial | 1 | 2018 | 843 | 0.11 | Why? |
| Aged | 19 | 2021 | 215776 | 0.10 | Why? |
| Length of Stay | 4 | 2021 | 11042 | 0.10 | Why? |
| Intensive Care Units | 5 | 2020 | 29594 | 0.10 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.10 | Why? |
| Exercise Therapy | 1 | 2018 | 976 | 0.10 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.09 | Why? |
| Antifungal Agents | 1 | 2019 | 1828 | 0.09 | Why? |
| Influenza A virus | 1 | 2020 | 2234 | 0.09 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.09 | Why? |
| Recovery of Function | 1 | 2018 | 2461 | 0.09 | Why? |
| Anti-HIV Agents | 2 | 2018 | 2209 | 0.09 | Why? |
| Hand Hygiene | 1 | 2018 | 1493 | 0.09 | Why? |
| Humans | 35 | 2021 | 930598 | 0.08 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.08 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.08 | Why? |
| Community-Acquired Infections | 1 | 2019 | 2328 | 0.08 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.08 | Why? |
| Lung Transplantation | 1 | 2017 | 1554 | 0.08 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.07 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
| Adult | 14 | 2020 | 244371 | 0.07 | Why? |
| Infant | 2 | 2017 | 30274 | 0.07 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.06 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.06 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.06 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.06 | Why? |
| Proportional Hazards Models | 3 | 2018 | 6543 | 0.05 | Why? |
| C-Reactive Protein | 4 | 2018 | 7972 | 0.05 | Why? |
| Risk Factors | 6 | 2019 | 71621 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.05 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.05 | Why? |
| Treatment Outcome | 4 | 2019 | 51732 | 0.05 | Why? |
| Follow-Up Studies | 4 | 2019 | 17020 | 0.05 | Why? |
| Seoul | 1 | 2019 | 206 | 0.05 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2017 | 5002 | 0.05 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.05 | Why? |
| Hyperlactatemia | 1 | 2017 | 13 | 0.04 | Why? |
| Pregnancy Rate | 1 | 2018 | 134 | 0.04 | Why? |
| Methicillin | 1 | 2018 | 73 | 0.04 | Why? |
| Osteocalcin | 1 | 2017 | 31 | 0.04 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.04 | Why? |
| Forensic Genetics | 1 | 2017 | 13 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Operative Time | 1 | 2019 | 450 | 0.04 | Why? |
| Live Birth | 1 | 2018 | 200 | 0.04 | Why? |
| Metronidazole | 1 | 2017 | 59 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2019 | 5440 | 0.04 | Why? |
| Lymph Node Excision | 1 | 2019 | 362 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.04 | Why? |
| Depression | 1 | 2020 | 14116 | 0.04 | Why? |
| Central Venous Catheters | 1 | 2018 | 188 | 0.04 | Why? |
| Plasmids | 1 | 2019 | 840 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.04 | Why? |
| Kidney Tubules | 1 | 2017 | 205 | 0.04 | Why? |
| Point Mutation | 1 | 2018 | 481 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Outpatient Clinics, Hospital | 1 | 2020 | 523 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Antibodies, Antinuclear | 1 | 2017 | 234 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Interleukin-1beta | 1 | 2020 | 992 | 0.04 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.04 | Why? |
| Ceftriaxone | 1 | 2017 | 365 | 0.04 | Why? |
| APACHE | 1 | 2017 | 682 | 0.04 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.03 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 449 | 0.03 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.03 | Why? |
| Likelihood Functions | 1 | 2017 | 719 | 0.03 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.03 | Why? |
| Serum Albumin | 1 | 2018 | 571 | 0.03 | Why? |
| Databases, Nucleic Acid | 1 | 2017 | 272 | 0.03 | Why? |
| Animals | 3 | 2018 | 78931 | 0.03 | Why? |
| Visitors to Patients | 1 | 2020 | 671 | 0.03 | Why? |
| Drug Utilization | 1 | 2019 | 619 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Hospital Departments | 1 | 2020 | 831 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Catheterization, Central Venous | 1 | 2018 | 458 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| beta-Lactamases | 1 | 2019 | 759 | 0.03 | Why? |
| Endoscopy, Digestive System | 1 | 2017 | 352 | 0.03 | Why? |
| Patients | 1 | 2020 | 1167 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2017 | 53120 | 0.03 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.03 | Why? |
| National Health Programs | 1 | 2019 | 807 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Platelet Count | 1 | 2018 | 1381 | 0.03 | Why? |
| Gene Frequency | 1 | 2017 | 1210 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Opportunistic Infections | 1 | 2018 | 602 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Withholding Treatment | 1 | 2017 | 798 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.03 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.03 | Why? |
| Sputum | 1 | 2019 | 1720 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2017 | 1475 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2019 | 27595 | 0.03 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.03 | Why? |
| Virulence | 1 | 2018 | 2172 | 0.03 | Why? |
| Medical Staff, Hospital | 1 | 2020 | 1258 | 0.03 | Why? |
| Prognosis | 3 | 2018 | 32490 | 0.03 | Why? |
| Antimicrobial Stewardship | 1 | 2018 | 931 | 0.03 | Why? |
| Program Evaluation | 1 | 2018 | 1929 | 0.02 | Why? |
| Patient Readmission | 1 | 2019 | 1543 | 0.02 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.02 | Why? |
| Single-Cell Analysis | 1 | 2020 | 2450 | 0.02 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.02 | Why? |
| Neoplasm Staging | 1 | 2017 | 1999 | 0.02 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2019 | 2259 | 0.02 | Why? |
| Cells, Cultured | 1 | 2020 | 5835 | 0.02 | Why? |
| L-Lactate Dehydrogenase | 1 | 2017 | 1995 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2019 | 3239 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Child | 1 | 2017 | 70012 | 0.02 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.02 | Why? |
| Nursing Staff, Hospital | 1 | 2020 | 1554 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Hematologic Neoplasms | 1 | 2019 | 2105 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Caregivers | 1 | 2020 | 3112 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Diet | 1 | 2017 | 2052 | 0.02 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.02 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.02 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2020 | 5837 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.01 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.01 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2018 | 5164 | 0.01 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3832 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
Jeong's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(261)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(116)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_